Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$19.59−0.20 (-1.01%)
Close on Nov 17, 2026Market cap $1.89BP/E –Yield –
Fortrea total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Fortrea's total debt was $1.06B at Sep 30, 2026. For fiscal 2025 it was $1.05B, down 6.4% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.05B | -6.4% |
| FY2024 | Dec 31, 2024 | $1.12B | -29.4% |
| FY2023 | Dec 31, 2023 | $1.59B | – |
| FY2022 | Dec 31, 2022 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.06B | -6.3% |
| Q2 FY2026 | Jun 30, 2026 | $1.05B | -10.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.05B | -13.2% |
| Q4 FY2025 | Dec 31, 2025 | $1.05B | -6.4% |
| Q3 FY2025 | Sep 30, 2025 | $1.13B | +0.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.18B | +4.6% |
| Q1 FY2025 | Mar 31, 2025 | $1.21B | -24.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.12B | -29.4% |
| Q3 FY2024 | Sep 30, 2024 | $1.12B | -29.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.12B | -30.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.61B | – |
| Q4 FY2023 | Dec 31, 2023 | $1.59B | – |
| Q3 FY2023 | Sep 30, 2023 | $1.60B | – |
| Q2 FY2023 | Jun 30, 2023 | $1.61B | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
See a number that looks wrong?